UKhetho loNyango olungaSebenziyo ngoku lweNgqondo eqhelekileyo yoMhlaza

Abanye abantu baseMelika abazizigidi ezi-3.3 baya kufunyaniswa bene-basal cell okanye umhlaza wolusu lwe-squamous cell kulo nyaka, kwaye omnye kwabane uya kuba nokufikelela kwinqanaba le-Image-Guided Superficial Radiotherapy (Image-Guided SRT), enye indlela engeyiyo yotyando kwi-Mohs utyando olwenziweyo. iyafumaneka kwiidermatologists kwilizwe lonke yi-SkinCure Oncology.

UKerwin J. Brandt, igosa elilawulayo le-SkinCure Oncology, uphawula ukuba inkampani yakhe ngoku isebenza ngeendlela ezingaphezu kwe-200 zedermatology kumazwe angama-34, kwaye yanda ngokukhawuleza, yongeza phantse iindawo ezintsha ze-10 ngenyanga. Inkampani ibonelela ngetekhnoloji ye-SRT eKhokelwa nguMfanekiso kumaqabane ayo asebenza kwi-dermatologist, kunye neqela leenkonzo zeklinikhi, zolawulo, kunye nenkxaso yokusebenza, ukuzisa ukhathalelo lwenqanaba leziko lomhlaza kwizigulana zomhlaza wolusu we-nonmelanoma.

Isitshixo ekuhanjisweni kwe-SRT eKhokelwe nguMfanekiso, ngaphezu kokuba neteknoloji efanelekileyo nge-Sensus Healthcare SRT-100 Vision™, ibonelela ngonyango oluneprotocol echanekileyo kunye nokulawulwa komgangatho ukufezekisa iziphumo eziphezulu zeklinikhi. I-SkinCure Oncology, ngenkqubo yayo evavanyiweyo, ibonelela ngeenkqubo zedermatology ngemodeli eqinisekisiweyo efikelela kumazinga onyango ebengenakufumaneka ngaphambili kwaye ngokulinganayo njengeziphumo zokwaneliseka kwesigulane.

“Kwiminyaka emihlanu edlulileyo,” utshilo uBrandt, “siye sa-odola iiyunithi ezingama-240 ze-SRT-100 Vision kwi-Sensus Healthcare esiqikelela ukuba zingaphezulu kwama-95 epesenti yazo zonke iiyunithi zoMbono ze-SRT-100 abazithengisileyo kwihlabathi liphela. Ngokucacileyo, siqhubeka singoyena mthengi wabo mkhulu kwaye sithathe ngaphezulu kwe-65 yepesenti yengeniso yabo kule minyaka mihlanu idlulileyo. Sikhethe ukulungelelanisa neSensus ngesizathu esinye esibaluleke kakhulu - ngokungafaniyo nabanye ababoneleli bezixhobo zemitha ezenzelwe ukunyanga umhlaza wolusu, iSensus idibanise isikhokelo somfanekiso kuyilo lwe-SRT-100 Vision. Le teknoloji, xa idityaniswa nendlela kunye nobuchule be-SkinCure Oncology, ivumela amaqabane ethu asebenza ngedermatology ukuba anyange izigulana nge-adaptive radiotherapy protocol ethambileyo kunolunye unyango olusekwe kwimitha kwaye isebenza ngakumbi ekunyangeni umhlaza wolusu.

Uphononongo olukhulu lwakutsha nje lubonise i-Image-Guided SRT ukuba ibenereyithi yonyango ye-99.3 yepesenti kuzo zombini i-basal kunye ne-squamous cell carcinomas. "Kwanotyando lwe-Mohs, apho ugqirha wotyando ukhupha iileyile zezicubu kude kube yimida ecocekileyo ifunyenwe, ayifumani ezo ziphumo," utshilo uJosh Swindle, umlawuli kazwelonke we-SkinCure Oncology.

U-Adam Lefton, igosa eliyintloko lenkampani ye-brand kunye nemfundo, wongeza, "Iziphumo zeklinikhi eziphezulu kunye nonyawo olukhula ngokukhawuleza lubalulekile kwiindlela zokuphumeza i-Image-Guided SRT, kodwa yinxalenye nje yebali. Sifumene iimpendulo zophando kwizigulane ezingaphezu kwe-7,200 emva konyango lokugqibela, kwaye i-99.9 yangaphambili yathi bobabini bonwabile ngesigqibo sabo sokunyangwa nge-Image-Guided SRT kwaye baya kucebisa ukuba ukhetho lonyango kwabanye. Abantu abanomhlaza wolusu bayakuxabisa ngokucacileyo ukuba nenye indlela engaphantsi kotyando lwe-Mohs, kunye nokudityaniswa kwezixhobo ze-SRT eziKhokelwe nguMfanekiso ezivela kwi-Sensus ngokuphunyezwa komgangatho wehlabathi, iiprothokholi, kunye nabasebenzi nge-SkinCure Oncology iyabutshintsha ubuso bomhlaza wolusu e-US. ”